<?xml version="1.0" encoding="UTF-8"?><rss version="0.92">
<channel>
	<title>FDA Voice &#187; 2012 &#187; September</title>
	<link>http://blogs.fda.gov/fdavoice</link>
	<description></description>
	<lastBuildDate>Tue, 18 Jun 2013 15:09:37 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.3.1" -->

	<item>
		<title>Treating Children with Cancer</title>
		<description><![CDATA[September is National Childhood Cancer Awareness Month. Watch the below video in which two FDA experts discuss existing and new efforts to encourage the development of medicines for kids with cancer. The conversation is between Robert “Skip” Nelson, M.D., Ph.D., deputy &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/09/treating-children-with-cancer/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/09/treating-children-with-cancer/</link>
			</item>
	<item>
		<title>Friends of Cancer Research Honors Our Dr. Richard Pazdur</title>
		<description><![CDATA[By: Margaret Hamburg, M.D. One of the privileges of being the head of the Food and Drug Administration is being able to report on the accomplishments of the dedicated and highly skilled employees who are advancing the public health mission &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/09/friends-of-cancer-research-honors-our-dr-richard-pazdur-2/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/09/friends-of-cancer-research-honors-our-dr-richard-pazdur-2/</link>
			</item>
	<item>
		<title>FDA Voice interviews Helene D. Clayton-Jeter, O.D., on the Cardiovascular and Endocrine Liaison Program</title>
		<description><![CDATA[FDA Voice: Thank you for blogging with FDA Voice today. Can you tell us about the Cardiovascular and Endocrine Liaison Program in FDA’s Office of Special Health Issues? Helene Clayton-Jeter: Millions of Americans have cardiovascular disease (CVD) and diabetes, and &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/09/fda-voice-interviews-helene-d-clayton-jeter-o-d-on-the-cardiovascular-and-endocrine-liaison-program/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/09/fda-voice-interviews-helene-d-clayton-jeter-o-d-on-the-cardiovascular-and-endocrine-liaison-program/</link>
			</item>
	<item>
		<title>FDA Voice interviews Paul C. Howard, Ph.D, on Nanotechnology</title>
		<description><![CDATA[FDA Voice: Thank you for taking time to discuss the exciting field of Nanotechnology with us.  We’ve heard so much about Nanotechnology – what is it exactly and why has it been tagged as the second industrial revolution? Dr. Howard:  &#8230; <a href="http://blogs.fda.gov/fdavoice/index.php/2012/09/fda-voice-interviews-paul-c-howard-ph-d-on-nanotechnology/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<link>http://blogs.fda.gov/fdavoice/index.php/2012/09/fda-voice-interviews-paul-c-howard-ph-d-on-nanotechnology/</link>
			</item>
</channel>
</rss>
